These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33443549)

  • 1. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic.
    Bakouny Z; Paciotti M; Schmidt AL; Lipsitz SR; Choueiri TK; Trinh QD
    JAMA Oncol; 2021 Mar; 7(3):458-460. PubMed ID: 33443549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey.
    Swan J; Breen N; Graubard BI; McNeel TS; Blackman D; Tangka FK; Ballard-Barbash R
    Cancer; 2010 Oct; 116(20):4872-81. PubMed ID: 20597133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Screening.
    Am Fam Physician; 2016 Apr; 93(8):Online. PubMed ID: 27175849
    [No Abstract]   [Full Text] [Related]  

  • 4. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia.
    Feletto E; Grogan P; Nickson C; Smith M; Canfell K
    Public Health Res Pract; 2020 Dec; 30(4):. PubMed ID: 33294902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of cancer screening after COVID-19 may be at home.
    Gorin SNS; Jimbo M; Heizelman R; Harmes KM; Harper DM
    Cancer; 2021 Feb; 127(4):498-503. PubMed ID: 33170520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational Challenges of a Low-Dose CT Lung Cancer Screening Program During the Coronavirus Disease 2019 Pandemic.
    Lang M; Yeung T; Shepard JO; Sharma A; Petranovic M; Flores EJ; McLoud TC; Som A; Saini S; Prabhakar AM; D Succi M; Little BP
    Chest; 2021 Mar; 159(3):1288-1291. PubMed ID: 33121979
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.
    De Vincentiis L; Carr RA; Mariani MP; Ferrara G
    J Clin Pathol; 2021 Mar; 74(3):187-189. PubMed ID: 32561524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer screening among Vietnamese in Hawaii.
    Nguyen LT; Withy K; Nguyen MM; Yamada S
    Hawaii Med J; 2003 Jul; 62(7):145-8. PubMed ID: 12971132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
    Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
    Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Digital Breast Tomosynthesis.
    Hooley RJ; Durand MA; Philpotts LE
    AJR Am J Roentgenol; 2017 Feb; 208(2):256-266. PubMed ID: 27786548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
    Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
    Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Google search volume trends for cancer screening terms during the COVID-19 pandemic.
    Snyder A; Jang S; Nazari IS; Som A; Flores EJ; Succi MD; Little BP
    J Med Screen; 2021 Jun; 28(2):210-212. PubMed ID: 33663240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Tomasik B; Braun M
    ESMO Open; 2021 Jun; 6(3):100108. PubMed ID: 33862335
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Toss A
    ESMO Open; 2021 Jun; 6(3):100109. PubMed ID: 33845361
    [No Abstract]   [Full Text] [Related]  

  • 16. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the Number of Procedures and Hospitalizations and Increase in Cancer Mortality During the COVID-19 Pandemic in Brazil.
    Fonseca GA; Normando PG; Loureiro LVM; Rodrigues REF; Oliveira VA; Melo MDT; Santana IA
    JCO Glob Oncol; 2021 Jan; 7():4-9. PubMed ID: 33405961
    [No Abstract]   [Full Text] [Related]  

  • 18. A new era in cervical cancer prevention.
    Roeske L
    Aust J Gen Pract; 2018 Jul; 47(7):405. PubMed ID: 30114878
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer screening falls during the COVID-19 pandemic.
    Cancer; 2022 Nov; 128(21):3755. PubMed ID: 36228161
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.